Legal Review of the Yaz Lawsuit
Plaintiffs that have already filed Yaz lawsuits have been compensated for damages of over $1 billion. The contraceptive drug which is sold under the brand name of Yaz is responsible for a number of side effects among its users. These side effects have forced Bayer to settle the lawsuits in lump sums. Bayer continues to settle cases of various plaintiffs with individual settlements of over $200 000. However, the amount of financial compensation given to individual plaintiffs is dependent on the magnitude of the damage caused by the defective drug Yaz.
History of the Yaz Lawsuit
The Food and Drug Administration (FDA) is responsible for approving the sale of drugs and other consumer products for release onto the market. The governing body approved the release of Yasmin manufactured by Bayer in 2001. Yaz, which was was meant to give a contraceptive option to women interested in birth control, was released in 2006.
Women use the drug for reasons other than contraception such as treating and clearing acne, managing symptoms of pre-menstrual dysphoric disorder (PMDD) and also to regulate their menstrual cycle. Doctors did not object to the use of the drug for these other reasons. Because of the consumer interest in the drug, the FDA approved the use of Yaz® for the treatment of PMDD in October 2006. A subsequent approval followed in January 2007 for the use of the Yaz drug to treat acne.
In 2003, the FDA issued a warning to Bayer to stop misleading the public with its running advertisements concerning Yasmin. They again issued a warning letter in 2008, this time because of ads for Yaz. These advertisements over emphasized the efficacy of Yaz and Yasmin while downplaying the risks associated with its use. Bayer was forced to re-run advertisements correcting its initial adverts of Yaz. The drug giant was also forced to make label adjustments on the Yaz product.
The first Yaz lawsuit first appeared in 2009 right after the FDA issued a warning to Bayer concerning the Yaz contraceptive drug. Patients using the drug filed Yaz lawsuits against Bayer for failure to issue warnings in due time.
The plaintiffs claimed that the drug caused blood clots and other serious complications that led to hospitalization, medical bills leading to financial strain, emotional anguish and other interferences to their normal lives.
Scientific Findings that Support the Yaz Lawsuit
In 2002, a 17-year old girl died because of complications known as venous thrombosis which was linked to the use of Yasmin. Soon after this incident, studies of the drug from independent researchers were set in motion to determine its safety. However, the findings in various studies were troubling.
Bayer claimed in its advertisements that its contraceptive drugs, Yaz and Yasmin, did not have side effects that were associated with other birth control pills. These Yaz Side Effects include liver disruption, high blood pressure, allergic reactions, weight gain, hair loss and other symptoms such as upper respiratory infections. However, studies showed that these claims were far from the truth.
The findings reported that Yaz contained Drospirenone, a synthetic hormone responsible for raising the potassium levels in the blood to dangerous levels. This increase in potassium leads to conditions such as deep vein thrombosis (DVT), blood clots, stroke and pulmonary embolism. The blood clots that start in the legs are perhaps the first and the main side effect of Yaz use which then leads to the development of the above mentioned life-threatening complications.
The research carried out by various scientists was published in notable sources including the American Journal of Medicine, British Medical Journal and the New England Journal of Medicine. Later, the FDA also released its own findings from studies done on users of the Yaz drug and the results matched those of other studies on blood clot related side effects.
On May 12, 2012, the institute for Safe Medicine Practices and QuarterWatch reported that Yaz and Yasmin drugs ranked second highest for the number of complications forwarded to the FDA in 2011.
To date, over fifty deaths have been linked to Yaz and reported to the FDA in the US alone.
Yaz Lawsuit: Multidistrict Litigation or a Class Action Suit?
The number of plaintiffs filing a Yaz lawsuit was so high; it became necessary to consolidate the cases into a Multidistrict litigation. Consolidation was done in an Illinois Court.
A Multidistrict litigation is necessary for cases filed against the same product so as to keep the judgments fair across the states. Cases of the plaintiffs being denied damage compensation when they are entitled to it are reduced, and everyone is given a fair chance to claim financial compensation for injury.
The Multidistrict litigation also allows cases to be heard on an individual basis and settlements awarded in accordance with the degree of damage caused by the product in question. The plaintiffs are also allowed the luxury of choosing their own legal counsel to represent them. However, there is usually a set time frame for plaintiffs to register for their lawsuit to be heard.
A Yaz Class Action suit is different from a Multidistrict litigation as it does not give plaintiffs an individual hearing. The class action suit only allows for uniform compensation regardless of the degree of injury incurred by a consumer of the product in question.
Bayer agreed to settle for blood clot injuries. Not every case qualifies for compensation. We advise you to get in touch with our attorneys and get counsel on your situation. Our legal experts have dealt with such cases and won hefty compensation sums for plaintiffs. If you have any questionable issues related to a Yaz lawsuit, please get in touch with us as soon as possible before time runs out.
Status of the Yaz Lawsuit
Over 11,000 American women have filed a lawsuit against Bayer for damages from using their defective product, Yaz. By March 2012, Bayer had settled over 5,000 of these cases and continues to do so.
Trials were postponed in favor of settlement talks which bore fruit because Bayer finally agreed to settle for Yaz injury arising from blood clots.
By July 2013, Bayer had paid $1.4 billion worth of Yaz settlements for 6,760 cases.
In August 2013, over 1,000 MDL cases had been settled with about 9,800 more cases pending so far.
It is important to talk to attorneys who are qualified to represent you in lawsuits such as the Yaz lawsuit in order to advise you on which legal method to follow. Federal litigations concerning defective drugs such as Yaz are usually complex in nature.
Contact us today if you suffer from severe side effects from Yaz, Yasmin or Ocella. We are experienced in dealing with lawsuits filed against drug companies and winning the plaintiffs maximum financial compensation. Our consultations are free and we can help you regardless of your location. We cover all fifty states in the US. We will fight to get you the maximum compensation for your Yaz lawsuit.